Overview

Long-Term Safety Performance of Fexofenadine in Asthma

Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long-term safety performance of fexofenadine compared to montelukast in subjects with asthma
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi
Treatments:
Fexofenadine
Montelukast
Terfenadine